Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Heart Rate Control With Ivabradine on Hemodynamic in Patients With Sepsis: a Prospective, Multicenter, Randomized Controlled Trial

NCT05882708 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Guangzhou Medical University as lead sponsor.

NCT NCT05882708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05882708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Heart Rate Control With Ivabradine on Hemodynamic in Patients With Sepsis: a Prospective, Multicenter, Randomized Controlled Trial
Lead sponsor
Second Affiliated Hospital of Guangzhou Medical University
Phase
Phase 4
Overall status
Recruiting
Start date
June 1, 2023
Completion date
May 31, 2027
Enrollment
172 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

heart rate control, hemodynamics, ivabradine, sepsis